# NeuroVerse v1.2.0-public-launch Release Notes

This release hardens the NeuroVerse platform runtime, making it audit-ready for technical recruiters, reviewers, and scientific coordinators. It introduces unified system diagnostic dashboard features, performance code-splitting optimizations, strict accessibility audits, and comprehensive safety governance documentation.

> [!IMPORTANT]
> **Official Release Status**:
> "NeuroVerse v1.2.0 is release-ready for public portfolio review. 
> Automated launch checks pass for the available software, static evidence, and reviewer workflows. 
> Physical OpenBCI/Galea validation remains pending unless a real device report exists. 
> This is a research-grade, safety-gated prototype, not a clinical or medical system."

---

## 1. High-Impact Enhancements

### A. Unified CommandCenter & Guided Walkthrough
- **Unified Health Aggregation**: The CommandCenter consolidates 8 health sectors, combining async protocol engine state, LSL adapter health, static portfolio configurations, and late-fusion metrics.
- **Reviewer guided tour**: An onboard interactive Step-by-Step guided tour banner steps reviewers through Safety State assertions, external research boundaries, and shadow explainability.
- **ProvenanceGraph**: Dynamic visualization separating modeling research boundaries (external Imagina exports) from real-time execution safety and visual adaptation limits (NeuroVerse sandbox).

### B. Production-Grade Performance Optimizations
- **React Code-Splitting**: Replaced monolithic component bundling with `React.lazy` and `Suspense`, successfully isolating the heavy 3D cinematic assets (Three.js, R3F) into an asynchronous bundle (`AppShell`).
- **Initial Entry Size Reduction**: Initial JavaScript load payload decreased to just `147.67 KB`, satisfying strict loading budgets.
- **Automated Bundle Size Auditing**: Embedded a new release check gate that blocks builds if Vite JS bundles exceed fail thresholds.

### C. Rigorous Security & Accessibility Hardening
- **Zero Critical Accessibility Failures**: Audited React DOM elements to assert proper focus states and hierarchical tag structures.
- **Threat Model Publication**: Authored the official [Security and Privacy Threat Model](file:///home/tonystark/Desktop/NeuroVerse/docs/SECURITY_AND_PRIVACY_THREAT_MODEL.md) detailing the local-first boundary philosophy.
- **Scientific Integrity Disclaimers**: Added standard visible disclaimers across components ensuring zero direct mind decoding or clinical-grade assertions.

---

## 2. Pass/Fail Validation Matrix

Below is the definitive verification status of all release pipeline quality gates:

| Verification Gate | Scope | Status | Notes / Metrics |
|---|---|---|---|
| **Backend tests** | `pytest app/tests/` | 🟢 **PASS** | Passed all backend tests cleanly. |
| **Smoke API check** | `make smoke-api` | 🟢 **PASS** | Verified registry alignment across 63 FastAPI endpoints. |
| **Static evidence check** | `make static-evidence-check` | 🟢 **PASS** | 0 checksum mismatches. Synchronized manifest without drift. |
| **Release check** | `make release-check` | 🟢 **PASS** | Verified the existence of all 23 release artifacts and threat models. |
| **Frontend lint** | `npm run lint` | 🟢 **PASS** | 0 ESLint or TypeScript compilation warnings. |
| **Frontend build** | `npm run build` | 🟢 **PASS** | Compiled successfully with dynamic lazy chunking outputs. |
| **Docker compose config**| `docker compose config` | 🟢 **PASS** | Compose configuration validated with `closed_loop_allowed=false`. |
| **public-launch-fast** | `make public-launch-fast` | 🟢 **PASS** | Integrated local checklist validators completed successfully. |

---

## 3. Scope Boundaries & Technical Limitations
- **Closed-Loop Isolation**: The real-time visual adaptation loop remains locked to a shadow-inference mode (`closed_loop_allowed = false`) by default.
- **Physical Hardware**: Galea/OpenBCI validations utilize high-fidelity synthetic signal emulators.
- **Clinical Non-Claim**: This codebase is an exploratory research prototype and must not be used for medical diagnosis, clinical trials, or cognitive treatment.
